Terns Pharmaceuticals, Inc. (TERN) Marketable Securities, Current USD 2020 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Terns Pharmaceuticals, Inc. quarterly Marketable Securities, Current history and growth rate from 2020 to 2024.
Terns Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $176 M, a 55.1% increase year-over-year.

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2024	$176 M	+$62.4 M	+55.1%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$184 M	+$43.6 M	+31.2%	Dec 31, 2023	10-Q	2024-05-13
Q3 2023	$229 M	+$104 M	+84%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$205 M	+$81.7 M	+66.4%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$113 M	+$5.78 M	+5.39%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$140 M	+$21.6 M	+18.3%	Dec 31, 2022	10-K	2024-03-14
Q3 2022	$124 M	+$11.9 M	+10.6%	Sep 30, 2022	10-Q	2022-11-09
Q2 2022	$123 M	+$5.51 M	+4.69%	Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$107 M	+$10.6 M	+11%	Mar 31, 2022	10-Q	2022-05-16
Q4 2021	$118 M	+$118 M		Dec 31, 2021	10-K	2023-03-27
Q3 2021	$112 M			Sep 30, 2021	10-Q	2021-11-15
Q2 2021	$117 M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$96.8 M			Mar 31, 2021	10-Q	2021-05-14
Q4 2020	$0			Dec 31, 2020	10-K	2022-03-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.